This is an observational prospective cross-sectional study, investigating the prevalence of primary aldosteronism in patients with atrial fibrillation.
Study Type
OBSERVATIONAL
Enrollment
120
Screening for primary aldosteronism will be performed with measurement of aldosterone-to-renin ratio after 2 hours of bed rest. Renin measurement will be performed by estimating plasma renin activity. The screening test will be considered positive when the ratio is \>30, accompanied by elevated aldosterone values (\>15 ng/ml). Patients with a positive result will undergo further confirmatory testing with intravenous sodium test (administration 2 liters of normal saline N/S 0.9%, over a period of 4 hours, while the patient is supine. Considered positive if aldosterone levels are \>5mg/dl at the end of the test). Alternative confirmatory methods are captopril test (Administration of 50 mg of captopril. Considered positive when aldosterone levels are \>8.5 mg/dl 2 hours after the intake) or hydrocortisone test (Administration of 0.1mg of hydrocortisone 4 times a day for a period of 4 days. Considered positive if elevated aldosterone levels (\>6ng/dl) are found at the end of the test).
Ippokratio General Hospital
Thessaloniki, Greece
RECRUITINGPrevalence of primary aldosteronism in patients with atrial fibrillation
Percentage of patients with positive screening and confirmatory test for primary aldosteronism
Time frame: Baseline
Association of marker of arterial stiffness with presence of primary aldosteronism in patients with atrial fibrillation
Pulse wave velocity
Time frame: Baseline
Association of echocardiographic indices with presence of primary aldosteronism in patients with atrial fibrillation.
Left ventricular global longitudinal strain (GLS) measured by transthoracic echocardiography
Time frame: Baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.